Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for UT Southwestern Medical Center located at 6201 Harry Hines Blvd, Dallas, TX, 75390 & includes data from NPIs 1285798918
Dexur analyzed Q2 2018 (April to June 2018) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for UT Southwestern Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,762 | 1,700 | ||||||||||
| Surgical | 589 | 573 | ||||||||||
| Non Surgical | 1,173 | 1,127 | ||||||||||
| Cardiovascular | 413 | 404 | ||||||||||
| General Medicine | 281 | 260 | ||||||||||
| General Surgery | 229 | 222 | ||||||||||
| Urology | 210 | 205 | ||||||||||
| Gastroenterology & Endocrinology | 166 | 164 | ||||||||||
| Pulmonology | 145 | 142 | ||||||||||
| Oncology & Hematology | 131 | 128 | ||||||||||
| Orthopedics | 53 | 49 | ||||||||||
| Neurology | 44 | 41 | ||||||||||
| Colorectal | 23 | 21 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 23 | 22 | ||||||||||
| Obstetrics & Gynecology | 23 | 21 | ||||||||||
| Dermatology | 12 | 12 |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Major Cardiovascular Procedures |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hiv With Major Related Condition | ||||||||||||
| Signs And Symptoms |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Respiratory System O.R. Procedures | ||||||||||||
| DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 167: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Chest Procedures | ||||||||||||
| Hernia Procedures | ||||||||||||
| Pancreas, Liver And Shunt Procedures |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 658: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Bladder Procedures | ||||||||||||
| DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney Transplant | ||||||||||||
| DRG 652: KIDNEY TRANSPLANT |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Digestive System Diagnoses | ||||||||||||
| DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Endocrine Disorders |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| Other Respiratory System Diagnoses | ||||||||||||
| DRG 206: OTHER RESPIRATORY SYSTEM DIAGNOSES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Pulmonary Embolism |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lymphoma And Non-Acute Leukemia | ||||||||||||
| Respiratory Neoplasms | ||||||||||||
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
| Digestive Malignancy |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Degenerative Nervous System Disorders |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Apr 2018 to Jun 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2018 to Jun 2018) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2018 to Jun 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures |